Work Here?
About CG Oncology
Industries
Biotechnology
Healthcare
Company Size
51-200
Company Stage
IPO
Headquarters
Irvine, California
Founded
2010
Overview
CG Oncology specializes in oncolytic immunotherapy, focusing on treatments that harness the body's immune system to combat cancer, particularly bladder cancer. Their main product, cretostimogene grenadenorepvec, is administered directly into the bladder and targets Non-Muscle Invasive Bladder Cancer (NMIBC) that does not respond to the standard Bacillus Calmette-Guérin (BCG) treatment. This therapy has side effects similar to other treatments in the same category. CG Oncology differentiates itself from competitors by concentrating specifically on bladder cancer and aiming to preserve the bladder in affected patients, enhancing their quality of life. The company's goal is to improve the dignity and well-being of patients with urologic cancers through effective immunotherapy solutions.
Simplify's Take
What believers are saying
- Cretostimogene grenadenorepvec has a high complete response rate of 75.2% in trials.
- The FDA granted Fast Track and Breakthrough Therapy designations to cretostimogene grenadenorepvec.
- CG Oncology raised $437M in their IPO, indicating strong financial backing.
What critics are saying
- Increased competition from similar bladder cancer treatments may impact market share.
- Potential regulatory delays could affect commercialization timelines for cretostimogene grenadenorepvec.
- High clinical trial costs could strain financial resources without additional funding.
What makes CG Oncology unique
- CG Oncology specializes in oncolytic immunotherapy for bladder cancer treatment.
- Their leading product, cretostimogene grenadenorepvec, targets Non-Muscle Invasive Bladder Cancer.
- The company focuses on bladder-sparing therapies, avoiding radical cystectomy.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$902M
Above
Industry Average
Funded Over
8 Rounds
Benefits
Remote Work Options
Unlimited Paid Time Off
401(k) Company Match
401(k) Retirement Plan
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Performance Bonus
Health Savings Account/Flexible Spending Account
Stock Price
Company News
CG Oncology reports best-in-disease durability data for cretostimogene at AUA 2025.
In 2024, biopharma therapeutics and platforms saw significant IPO activity, raising $6.8 billion across 26 IPOs. Notable IPOs include CG Oncology's $437M in January, Kyverna Therapeutics' $367M in February, Bicara Therapeutics' $362M in August, Septerna's $331M in October, and Upstream Bio's $293M in September. Overall, the sector experienced increased deal activity and higher capital raised compared to 2023, indicating a stronger financing environment.
CG Oncology (NASDAQ: CGON) announced its participation in the 40th Annual European Association of Urology (EAU) Congress in Madrid, Spain, from March 21-24, 2025.
IRVINE, Calif., Feb. 26, 2025 (GLOBE NEWSWIRE) - CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer, today announced that Arthur Kuan, Chairman & Chief Executive Officer, is scheduled to present at the TD Cowen 45th Annual Health Care Conference in Boston, MA on Wednesday, March 5, 2025, at 11:10 am ET.
CG Oncology (CGON) has announced a public offering of 8 million shares at $28 each, aiming to raise $204 million. The company is offering 7.3 million shares, with an existing stockholder offering 700,000 shares. The offering is expected to close on December 16, 2024. Underwriters, including Morgan Stanley and Goldman Sachs, have a 30-day option to purchase an additional 1.2 million shares.
CG Oncology is Hiring for 6 Jobs on Simplify!
Find jobs on Simplify and start your career today
About CG Oncology
Industries
Biotechnology
Healthcare
Company Size
51-200
Company Stage
IPO
Headquarters
Irvine, California
Founded
2010
CG Oncology is Hiring for 6 Jobs on Simplify!
Find jobs on Simplify and start your career today